HomeInsightsStock Comparison

Kilitch Drugs India Ltd vs Themis Medicare Ltd Stock Comparison

Kilitch Drugs India Ltd vs Themis Medicare Ltd Stock Comparison

Last Updated on: Jun 05, 2025

Key Highlights

  • The Latest Trading Price of Kilitch Drugs (India) Ltd is ₹ 438.05 as of 05 Jun 15:30.
  • The P/E Ratio of Kilitch Drugs (India) Ltd changed from 147.7 on March 2020 to 42.9 on March 2024 . This represents a CAGR of -21.91% over 5 yearsThe P/E Ratio of Themis Medicare Ltd changed from 8.9 on March 2020 to 46.3 on March 2024 . This represents a CAGR of 39.07% over 5 years.
  • The Market Cap of Kilitch Drugs (India) Ltd changed from ₹ 125.4 crore on March 2020 to ₹ 626.97 crore on March 2024 . This represents a CAGR of 37.97% over 5 yearsThe Market Cap of Themis Medicare Ltd changed from ₹ 220.51 crore on March 2020 to ₹ 2015 crore on March 2024 . This represents a CAGR of 55.67% over 5 years.
  • The revenue of Kilitch Drugs (India) Ltd for the Mar '25 is ₹ 62.92 crore as compare to the Dec '24 revenue of ₹ 57.89 crore. This represent the growth of 8.69% The revenue of Themis Medicare Ltd for the Mar '25 is ₹ 73.25 crore as compare to the Dec '24 revenue of ₹ 94.83 crore. This represent the decline of -22.76%.
  • The ebitda of Kilitch Drugs (India) Ltd for the Mar '25 is ₹ 16.29 crore as compare to the Dec '24 ebitda of ₹ 10.46 crore. This represent the growth of 55.74% The ebitda of Themis Medicare Ltd for the Mar '25 is ₹ -6.14 crore as compare to the Dec '24 ebitda of ₹ 6.99 crore. This represent the decline of -187%.
  • The net profit of Kilitch Drugs (India) Ltd changed from ₹ 3.06 crore to ₹ 10.22 crore over 8 quarters. This represents a CAGR of 82.75% The net profit of Themis Medicare Ltd changed from ₹ 18.19 crore to ₹ -9.66 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Kilitch Drugs (India) Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Themis Medicare Ltd changed from 10.11 % on March 2020 to 18.59 % on March 2024 . This represents a CAGR of 12.96% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Kilitch Drugs (India) Ltd

  • Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe.
  • Their extensive research efforts have led to development of comprehensive, diverse and highly complementary portfolio of medicines targeting a wide spectrum of chronic and acute treatments which includes Sterile dosages namely Injectables & Ophthalmic, Effervescent tablets & Granules, Tablets & Capsules, OTC range covering varied Nutraceuticals & Cosmetics and Medical devices. The Company is engaged in development, manufacturing and marketing of quality finished dosages.
  • The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia.

About Themis Medicare Ltd

  • Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969.
  • The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993.
  • Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001.
  • The Group is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. In Mar.'95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital.

Kilitch Drugs (India) Ltd News Hub

News

Kilitch Drugs (India) to convene board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 19 M...

Read more

14 May 2025 11:58

News

Kilitch Drugs (India) to convene board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 11 F...

Read more

04 Feb 2025 15:55

News

Kilitch Drugs (India) announces board meeting date

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 12 N...

Read more

05 Nov 2024 13:41

News

Kilitch Drugs (India) to convene AGM

Kilitch Drugs (India) announced that the 32th Annual General Meeting (AGM) of the company ...

Read more

31 Aug 2024 15:38

News

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 Au...

Read more

02 Aug 2024 17:27

News

Kilitch Drugs (India) to declare Quarterly Result

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 27 M...

Read more

20 May 2024 19:21

Themis Medicare Ltd News Hub

News

Board of Themis Medicare recommends final dividend

Themis Medicare announced that the Board of Directors of the Company at its meeting held o...

Read more

21 May 2025 11:37

News

Themis Medicare to declare Quarterly Results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 20 May 202...

Read more

16 May 2025 16:53

News

Themis Medicare to discuss results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 14 Februar...

Read more

11 Feb 2025 10:53

News

Themis Medicare to discuss results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 25 October...

Read more

19 Oct 2024 10:22

News

Themis Medicare to hold board meeting

Themis Medicare will hold a meeting of the Board of Directors of the Company on 26 July 20...

Read more

17 Jul 2024 09:49

News

Board of Themis Medicare recommends final dividend

Themis Medicare announced that the Board of Directors of the Company at its meeting held o...

Read more

15 May 2024 10:44

SWOT Analysis Of Kilitch Drugs (India) Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Themis Medicare Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Kilitch Drugs (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Themis Medicare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Kilitch Drugs (India) Ltd and Themis Medicare Ltd

Which company has a larger market capitalization, Kilitch Drugs (India) Ltd or Themis Medicare Ltd?

Market cap of Kilitch Drugs (India) Ltd is 704 Cr while Market cap of Themis Medicare Ltd is 1,276 Cr

What are the key factors driving the stock performance of Kilitch Drugs (India) Ltd and Themis Medicare Ltd?

The stock performance of Kilitch Drugs (India) Ltd and Themis Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kilitch Drugs (India) Ltd and Themis Medicare Ltd?

As of June 5, 2025, the Kilitch Drugs (India) Ltd stock price is INR ₹438.05. On the other hand, Themis Medicare Ltd stock price is INR ₹138.7.

How do dividend payouts of Kilitch Drugs (India) Ltd and Themis Medicare Ltd compare?

To compare the dividend payouts of Kilitch Drugs (India) Ltd and Themis Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions